These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 25324899)

  • 1. Role of long-chain and very-long-chain polyunsaturated fatty acids in macular degenerations and dystrophies.
    Liu A; Lin Y; Terry R; Nelson K; Bernstein PS
    Clin Lipidol; 2011; 6(5):593-613. PubMed ID: 25324899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetics and molecular pathology of Stargardt-like macular degeneration.
    Vasireddy V; Wong P; Ayyagari R
    Prog Retin Eye Res; 2010 May; 29(3):191-207. PubMed ID: 20096366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Stargardt-3 macular dystrophy protein (ELOVL4) in the biosynthesis of very long chain fatty acids.
    Agbaga MP; Brush RS; Mandal MN; Henry K; Elliott MH; Anderson RE
    Proc Natl Acad Sci U S A; 2008 Sep; 105(35):12843-8. PubMed ID: 18728184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutant ELOVL4 that causes autosomal dominant stargardt-3 macular dystrophy is misrouted to rod outer segment disks.
    Agbaga MP; Tam BM; Wong JS; Yang LL; Anderson RE; Moritz OL
    Invest Ophthalmol Vis Sci; 2014 May; 55(6):3669-80. PubMed ID: 24833735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel ELOVL4 variant, L168S, causes early childhood-onset Spinocerebellar ataxia-34 and retinal dysfunction: a case report.
    Gyening YK; Boris K; Cyril M; Brush RS; Nassogne MC; Agbaga MP
    Acta Neuropathol Commun; 2023 Aug; 11(1):131. PubMed ID: 37568198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of ELOVL4 and very long-chain polyunsaturated fatty acids in mouse models of Stargardt type 3 retinal degeneration.
    Barabas P; Liu A; Xing W; Chen CK; Tong Z; Watt CB; Jones BW; Bernstein PS; Križaj D
    Proc Natl Acad Sci U S A; 2013 Mar; 110(13):5181-6. PubMed ID: 23479632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal expression of an Elovl4 transgene rescues neonatal lethality of homozygous Stargardt disease-3 mice.
    McMahon A; Butovich IA; Kedzierski W
    J Lipid Res; 2011 Jun; 52(6):1128-1138. PubMed ID: 21429867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hetero-oligomeric interactions of an ELOVL4 mutant protein: implications in the molecular mechanism of Stargardt-3 macular dystrophy.
    Okuda A; Naganuma T; Ohno Y; Abe K; Yamagata M; Igarashi Y; Kihara A
    Mol Vis; 2010 Nov; 16():2438-45. PubMed ID: 21139992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Approaches for Elongation of Fish Oils into Very-Long-Chain Polyunsaturated Fatty Acids and Their Enzymatic Interesterification into Glycerolipids.
    Honzíková T; Agbaga MP; Anderson RE; Brush R; Ahmad M; Musílková L; Šejstalová K; Alishevich K; Beneš R; Šimicová P; Berčíková M; Filip V; Kyselka J
    J Agric Food Chem; 2023 Nov; 71(46):17909-17923. PubMed ID: 37947776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mouse Models of Stargardt 3 Dominant Macular Degeneration.
    Barabas P; Gorusupudi A; Bernstein PS; Krizaj D
    Adv Exp Med Biol; 2016; 854():137-43. PubMed ID: 26427404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DHA does not protect ELOVL4 transgenic mice from retinal degeneration.
    Li F; Marchette LD; Brush RS; Elliott MH; Le YZ; Henry KA; Anderson AG; Zhao C; Sun X; Zhang K; Anderson RE
    Mol Vis; 2009 Jun; 15():1185-93. PubMed ID: 19536303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinal pathology and skin barrier defect in mice carrying a Stargardt disease-3 mutation in elongase of very long chain fatty acids-4.
    McMahon A; Butovich IA; Mata NL; Klein M; Ritter R; Richardson J; Birch DG; Edwards AO; Kedzierski W
    Mol Vis; 2007 Feb; 13():258-72. PubMed ID: 17356513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of adipose and red blood cell lipids with severity of dominant Stargardt macular dystrophy (STGD3) secondary to an ELOVL4 mutation.
    Hubbard AF; Askew EW; Singh N; Leppert M; Bernstein PS
    Arch Ophthalmol; 2006 Feb; 124(2):257-63. PubMed ID: 16476896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deciphering mutant ELOVL4 activity in autosomal-dominant Stargardt macular dystrophy.
    Logan S; Agbaga MP; Chan MD; Kabir N; Mandal NA; Brush RS; Anderson RE
    Proc Natl Acad Sci U S A; 2013 Apr; 110(14):5446-51. PubMed ID: 23509295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elovl4 5-bp deletion does not accelerate cone photoreceptor degeneration in an all-cone mouse.
    Schori C; Agbaga MP; Brush RS; Ayyagari R; Grimm C; Samardzija M
    PLoS One; 2018; 13(1):e0190514. PubMed ID: 29293603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biosynthesis of very long-chain polyunsaturated fatty acids in hepatocytes expressing ELOVL4.
    Agbaga MP; Logan S; Brush RS; Anderson RE
    Adv Exp Med Biol; 2014; 801():631-6. PubMed ID: 24664752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Cellular Functions of Very Long Chain-Fatty Acids: Insight From ELOVL4 Mutations.
    Deák F; Anderson RE; Fessler JL; Sherry DM
    Front Cell Neurosci; 2019; 13():428. PubMed ID: 31616255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ELOVL4: Very long-chain fatty acids serve an eclectic role in mammalian health and function.
    Hopiavuori BR; Anderson RE; Agbaga MP
    Prog Retin Eye Res; 2019 Mar; 69():137-158. PubMed ID: 30982505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haploinsufficiency is not the key mechanism of pathogenesis in a heterozygous Elovl4 knockout mouse model of STGD3 disease.
    Raz-Prag D; Ayyagari R; Fariss RN; Mandal MN; Vasireddy V; Majchrzak S; Webber AL; Bush RA; Salem N; Petrukhin K; Sieving PA
    Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3603-11. PubMed ID: 16877435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ELOVL4 Mutations That Cause Spinocerebellar Ataxia-34 Differentially Alter Very Long Chain Fatty Acid Biosynthesis.
    Gyening YK; Chauhan NK; Tytanic M; Ea V; Brush RS; Agbaga MP
    J Lipid Res; 2023 Jan; 64(1):100317. PubMed ID: 36464075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.